Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma

MicroRNA-mediated gene regulations in human sarcomas

(2012) Subbaya Subramanian et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

miR-210: a therapeutic target in cancer

(2012) Liu Hong et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

High expression of miR-210 predicts poor survival in patients with breast cancer: A meta-analysis

(2012) Liu Hong et al.   GENE

Identification of a Signaling Axis HIF-1α/MicroRNA-210/ISCU Independent ofSDHMutation That Defines a Subgroup of Head and Neck Paragangliomas

(2012) Anna Merlo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

microRNAs in cancer management

(2012) Yi W Kong et al.   LANCET ONCOLOGY

Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature

(2011) J. PosthumaDeBoer et al.   CLINICAL & EXPERIMENTAL METASTASIS

Expression of microRNA 210 associates with poor survival and age of tumor onset of soft-tissue sarcoma patients

(2011) T. Greither et al.   INTERNATIONAL JOURNAL OF CANCER

Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer

(2011) Françoise Rothé et al.   PLoS One

MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease

(2009) J. Wang et al.   Cancer Prevention Research

miR-210 promotes osteoblastic differentiation through inhibition ofAcvR1b

(2009) Yosuke Mizuno et al.   FEBS LETTERS

An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210

(2009) Pasquale Fasanaro et al.   JOURNAL OF BIOLOGICAL CHEMISTRY